Efficacy and Safety of Risankizumab in Genital or Scalp Psoriasis in the UnlIMMited Phase 4 Randomized Clinical Trial at Week 16

20250 citationsJournal Articlegold Open Access

Authors

ClinicalTrials.gov identifier NCT05969223.

Published in: Dermatology and Therapy

Volume 16, Issue 1, pp. 293-307

Field-Weighted Citation Impact: 0.00